De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Sihuan Pharmaceutical Holdings Group Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Sihuan Pharmaceutical Holdings Group heeft een totaal eigen vermogen van CN¥5.1B en een totale schuld van CN¥1.1B, wat de schuld-eigenvermogensverhouding op 21.4% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥11.5B en CN¥6.4B.
Belangrijke informatie
21.4%
Verhouding schuld/eigen vermogen
CN¥1.09b
Schuld
Rente dekkingsratio | n/a |
Contant | CN¥4.86b |
Aandelen | CN¥5.09b |
Totaal verplichtingen | CN¥6.44b |
Totaal activa | CN¥11.53b |
Recente financiële gezondheidsupdates
Is Sihuan Pharmaceutical Holdings Group (HKG:460) Using Too Much Debt?
Sep 30Health Check: How Prudently Does Sihuan Pharmaceutical Holdings Group (HKG:460) Use Debt?
Oct 31Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Oct 11Sihuan Pharmaceutical Holdings Group (HKG:460) Seems To Use Debt Rather Sparingly
Sep 26Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Dec 21Recent updates
What Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) 25% Share Price Gain Is Not Telling You
Oct 02Is Sihuan Pharmaceutical Holdings Group (HKG:460) Using Too Much Debt?
Sep 30Here's Why It's Unlikely That Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO Will See A Pay Rise This Year
May 31Investors Still Waiting For A Pull Back In Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
May 27A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Dec 05Health Check: How Prudently Does Sihuan Pharmaceutical Holdings Group (HKG:460) Use Debt?
Oct 31Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Aug 19Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Apr 21Is Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Worth HK$0.8 Based On Its Intrinsic Value?
Nov 03Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Oct 11Is There An Opportunity With Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) 34% Undervaluation?
Jun 21Estimating The Intrinsic Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Mar 09A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Nov 28Sihuan Pharmaceutical Holdings Group (HKG:460) Seems To Use Debt Rather Sparingly
Sep 26We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO For Now
Jun 22How Does Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Fare As A Dividend Stock?
May 11Sihuan Pharmaceutical Holdings Group's (HKG:460) Shareholders May Want To Dig Deeper Than Statutory Profit
Mar 30How Much Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Do Insiders Own?
Mar 07Should You Buy Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) For Its Dividend?
Feb 07Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Jan 11Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Dec 21Why Sihuan Pharmaceutical Holdings Group's (HKG:460) CEO Pay Matters
Dec 07Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( CN¥6.7B ) 460 } overtreffen de korte termijn passiva ( CN¥4.1B ).
Langlopende schulden: De kortetermijnactiva 460 ( CN¥6.7B ) overtreffen de langetermijnschulden ( CN¥2.3B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 460 heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van 460 is de afgelopen 5 jaar gestegen van 0.2% naar 21.4%.
Schuldendekking: De schuld van 460 wordt niet goed gedekt door de operationele kasstroom ( 19.1% ).
Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van 460 op haar schulden goed worden gedekt door EBIT.